Seven things to know:
1. Fourth quarter sales were up 2.6 percent to $2.1 billion, with knee products leading the way. Knee product sales were up nearly 4.3 percent to $761 million during the quarter, while hips were up 2.7 percent to $511 million. Spine and craniomaxillofacial sales were down 0.3 percent to $197 million.
2. Full year sales were up 0.8 percent to nearly $8 billion. Knee sales were up 1.3 percent to $2.8 billion while hip sales were up 0.7 percent to $1.9 billion. Full year spine and craniomaxillofacial sales were down 2.2 percent to $747 million.
3. Sales in the Americas were up 0.8 percent for the year, hitting $4.8 billion. The European sales were down 3.1 percent, but Asian Pacific sales were up 5.1 percent.
4. During 2019, Zimmer Biomet paid down $716 million of debt, net of debt proceeds, and paid $197 million in dividends. The company reported operating cash flow at $423 million and free cash flow of $295 million for the fourth quarter.
5. Zimmer Biomet expects 2020 reported revenue to increase 2.5 percent to 3.5 percent.
6. Net earnings for 2019 were $1.1 billion, up from $379.2 million net loss in 2018.
7. The Rosa Knee System, the company’s robotic knee system, accelerated sales from the third to the fourth quarter.
More articles on orthopedic devices:
10 device company executive moves
Maruho Medical acquires orthopedic device company
Atlas Spine launches cervical plating system
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
